pexels-photo-356054.jpegWritten by Dr. José Lapenta

Perhaps the first thing you ask is why a Dr. who lives in the Southern HEMISPHERE where this disease does not exist, – because the ticks in this continent, at least in this country are NOT CARRIERS OF THE BORRELIA BURGDORFERI, – giving him so much Importance to LYME DISEASE. 

(I must insert that Lyme has been confirmed in South America:  Here in the U.S., the infamous Speilman maps have ruled like the iron curtain, but they too have been proven faulty: – scroll down to “Legends of the North.”  Lyme is everywhere.  Period.

I’ll give you the answer: I’ll remind you that I’m the son of a dermatologist WHO WAS A GREAT INVESTIGATOR IN THE LEPROSY FIELD: read THE LEPROSY IN CAPE WHITE, AND THE LEPROSY IN THE ISLAND OF PROVIDENCIA. I particularly inherit his LEGACY and I am advocated at this time to give my help and support to both investigators and patients suffering this terrible disease.

As initial information I will tell you that when I publish the article on February 1, 2017 LOOKING FOR A VACCINE FOR LYME DISEASE I do not imagine that after 4 months of published continue in the first place of the most read. This fact led me to think that something is happening with this disease in the NORTHERN HEMISPHERE which is the most affected and I began to investigate more thoroughly the disease and its consequences.

Later published on May 7, 2017 the article THE LYME DISEASE, DEMENTIA AND ALZHEIMER, emphasizing that the late phase of the disease called NEUROBORRELIOSIS may be involved in neurological damage that may contribute to the development of ALZHEIMER AND DEMENTIA.

Remember that the BORRELIA BURGDORFERI, whatever its type, is a SPIROCHETE just like the TREPONEMA PALLIDUM, causal agent of the SYPHILLIS. If we compare both diseases we will have both have 3 STAGES: PRIMARY, SECONDARY AND TERTIARY. In SYPHILLIS THE TERTIARY STAGE is called NEUROSYPHILLIS, in BORRELIOSIS, is called NEUROBORRELIOSIS, both affect the brain.


1.) Abnormal gait.
2.) Blindness.
3.) Confusion, disorientation.
4.) Sudden personality changes.
5.) Changes in mental stability.
6.) Dementia.
7.) Depression.
8.) Headache.
9.) Urinary and fecal incontinence.
10.) Irritability.
11.) Memory problems.
12.) Mood alterations.
13.) Numbness in toes, feet or legs.
14.) Poor concentration.
15.) Psychosis.
16.) Convulsions.
17.) Rigidity in the neck.
18.) Tremors.
19.) Visual disturbances, sign of the pupils of Argyll Robertson.
20.) Muscle weakness.
21.) Abnormal reflexes.
22.) Muscle atrophy.
23.) Muscle contractions.


1.) Transverse Myelitis.
2.) Ankle pain.
3.) Flu-like symptoms.
4.) Eruption.
5.) Peripheral blindness.
6.) Muscle aches.
7.) Inflammation and pain of the joint.
8.) ANA Positive (Anti-Nuclear Antibodies).
9.) Migraines.
10.) Headaches.
11.) General malaise.
12.) Bone pain.
13.) Pain in the body.
14.) Fatigue.
15.) Severe pain in the joints.
16.) Fibromyalgia.
17.) Crisis of paralysis.
18.) Autoimmune reaction.
19.) Burning sensation on the skin.
20.) Swollen feet.
21.) The joints: migratory pain.
22.) Functional incapacity of the hands with pain.
23.) Severe pain: hand, wrist, shoulder, knees, ankles, neck.
24.) Decreased work performance.
25.) Raynaud’s disease (hands).
26.) Cracking of the tips of the fingers.
27.) Depression.
28.) Guillan Barre syndrome.
29.) Polymeric demyelinating chronic inflammatory neuropathy.
30.) Weakness of the legs.
31.) Sensitivity to light and sound.
32.) Headache, sinus and pressure.
33.) Tingling in hands, arms, legs and feet.
34.) Rigidity, weakness and trembling in hands and arms.
35.) Loss of balance.
36.) Dizziness, and an inability to focus / concentrate.
37.) Monthly menstrual migraines that began immediately after the vaccine and continued for 10 months.
38.) Chronic fatigue syndrome.
39.) Neuropathic pain.
40.) Severe sinusitis.
41.) Severe insomnia.
42.) Uncontrolled crying.
43.) Memory failure.
44.) Muscular atrophy and demyelination of the nerves.
45.) Visual markings.
46.) Tendonitis.
47.) Arthritis.

If you analyze both sets of SIGNS AND SYMPTOMS, they are the same, except for CONVULSIONS and URINARY INCONTINENCE that are manifested in NEUROSYPHILLIS.

This means that the LYMERix vaccine causes symptoms similar to NEUROSYPHILLIS, or tertiary syphilis, causes auto antibodies ANA, autoimmune diseases and many more, I am only talking about 12 cases, practically destroyed life in many of them that was TOTALLY HEALTHY. Is incredible!!

Another fact to know is the PATIENTS WHO ARE HLA-DR4, are more likely to manifest reactions to the vaccine LYMERix, this means that in your immunological composition you have an antigenic marker or ALLELE DENOMINATED DR4, which is determined with a blood test and If you are a carrier, the LYMERix vaccine will show more side effects, one of the cases I put here said that the laboratory NEVER SAID THAT ABOUT THE HLA-DR4, AND HE WAS.



ADVERSE EFFECTS: (SEE ATTACHED), in parentheses the number of cases)

1.) ARTHRALGIA (322).
2.) MYALGIA (227).
3.) PAIN (196).
4.) ASTHENIA (167).
5.) FEVER (126).
6.) FLU SYNDROME (124)
8.) RASH (85).






SUMMARIZING: 229 people WERE practically “KILLED” by placing the LYMErix VACCINE, which means: Looking for a solution they found the death.

SUDDENLY you will say, but Dr., that was many years ago between 1998-2.002, more than 15 years have passed, but I brought this subject today because the production of a NEW VACCINE for LYME disease is already underway.

The LYMERix vaccine was based on (Recombinat OspA) a surface protein A of BORRELIA BURGDORFERI and unfortunately was a tremendous failure. There I put all the studies that I found about it. So you can draw your conclusions.

And I end this POST with some quotes from the patients affected by the LYMErix VACCINE:

“…..Smithkline should not be able to destroy people’s lives as they have destroyed mine …”

“… As of May 8, 2000 there were 467 adverse reactions reported to VAERS, and of them 144 had complained of some sort of joint pain. Please do not let this vaccine hurt anymore people. I know SmithKline is trying to get it approved for children, PLEASE DO NOT LET THEM HURT ANYMORE KIDS…”

“….. The FDA let them put this on the market without fully testing it. The longer that this is left on the market, the more people are going to get hurt. Please stop this madness and
take it off the market…”

“….. No one else should ever suffer such profound life changes through the administration of a “safe” vaccine. He would have been far better off to get Lyme Disease than to be incapacitated by something we counted on to protect his health!…”

“….Please stop this vaccine from wrecking more lives! !Respectfully submitted…”


“….. 1. Doctors don’t know how to handle the rash of side effects. 2. Doctors don’t want to feel their at fault for the vaccine causing effects. 3. Patients are suffering because doctors don’t want to deal with Lyme let alone the vaccine…”

They were not even ready for what could happen ….

This review is dedicated to all researchers, doctors and people advocated in the fight against LYME disease, and at the same time it is a warning to LABORATORIES and MANUFACTURERS, that before launching a new vaccine, they will be sure to test it well for not cause harm to patients including death. !!!

In the references and attach the facts.

Greetings to all.

Dr. José Lapenta.

FDA Vaccine Advisory Committee, January 8, 2001. LYMErix vaccine victim’s stories
1.) CASE No 1:
2.) CASE No 2:
3.) CASE No 3
4.) CASE No 4
5.) CASE No 5
6.) CASE No 6
7.) CASE No 7
8.) CASE No 8
9.) CASE No 9
10.) CASE No 10
11.) CASE No. 11
12.) CASE No 12
14.) Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
15.) Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
16.) An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope.
17.) Safety, immunogenicity, and efficacy of Borrelia burgdorferi outer surface protein A (OspA) vaccine: A meta-analysis.
18.) Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.
19.) Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.
20.) Intentions to receive a potentially available Lyme disease vaccine in an urban sample.
FDA Vaccine Advisory Committee, January 8, 2001.
1.) CASE No 1:
To Whom It May Concern:
I am unable to attend the January 3 1 FDA Vaccine Advisory Committee meeting due to a
restrictive condition, , resulting from the Lymerix vaccine. In the spring of
1999, I decided to get the series of Lymerix shots, after, viewing a verv convincing TV
commercial touting the importance of protecting oneself from Lyme Dise:ase. I felt this would be a good thing to take advantage of since I had had numerous bites from the ticks which cause
Lyme Disease.

I was given the fust shot of the series on April 20, 1999. Thirteen days later, I collapsed,
completely paralyzed. Many tests at the hospital confirmed the di&nosis of Transverse Myelitis
– inflammation of the myelin sheath around the spinal cord. After days in Intensive Care at the
hospital, I was transferred to the Rehabilitation Center where I spent six months. After intensive
physical and occupational therapy, some mobility returned, but I am in a wheelchair most of the
time. My life has been drastically changed for the past 21 months. Up to the day I collapsed, I
was constantly on the go with meetings of historical societies and community organizations,
church activities, house tours, dinner parties, exercise classes, bus trips, theater outings, concerts, etc. I used to wear my daughters out, just telling them about all of the running around I did. Iused to be a world traveler, but now because of physical liitations, I stay close to home. I amable to live at home onlv with sunport from family and friends, and a paid nighttime caregiver.

For the first nine months after coming home from the Rehabilitation Center, I required round-
the-clock caregivers.

Prior to the Lymerix vaccine, I was in excellent health and completely independent. I
strongly urge you to take Lymerix off the market to spare others the pain and suffering it can

Very truly yours,
2.) CASE No 2:
My name is

and I have been asked to speak on behalf ofmy daughter,
‘. had a pretty normal childhood and
adolescence until the year 1999. Until that point in time, she had a very
active life. She had a horse that she used for exercise and enjoyment. She
had competed on him in various venues. They enjoyed jumping and dressage.
She volunteered in a therapeutic riding barn and worked with multiply
handicapped children. Her plans were to get her degree in veterinary medicine
and have a small animal practice. She held down a job at a vet’s office and
loved going to work and facing the challenges there.ln the !spring of that
year, I decided to get her the lyme vaccine. She was in contact with various
animals daily and spent a lot of time in the woods with horses. It seemed like
a good idea at the time. She had had a simple case of unconfirmed Lyme
Disease when she was around 12 years old and it seemed to respond to
antibiotics, so I thought Lymerix would be a good idea. My primary doctor
looked over the literature and agreed to give this series of injections. Our
lives have never been the same.

After the 2nd injection, –complained of ankle pain. I took her to an orthopedic
surgeon who couldn’t find anything wrong at the time. We sent her for physical
therapy and gave her medication. She made the best of it and never really got much better. She
had vague complaints of other joints bothering her, but again she kept
plugging along. She developed flulike symptoms, a rash, and woke up on
October 3 1 st, 1999 with peripheral blindness. She was having terrible muscle
aches and joint swelling and pain. We went to many specialists. Finally, we
decided to test her for HLA-dr4 ad lo and behold we had a positive. We also
had a positive ANA. To this day, she continues to test negative for Lyme,
MS, Lupus, Crohn’s Disease and all of the other autoimmune illnesses that
our doctors assumed were the possible cause. Their is no history of juvenile
arthritis in either side of the family. Her arthritis just kept getting worse,
even with treatments of anti inflammatories
and all of the arthritis medications on the market. She spent her entire
senior year at home, too ill to even walk through the hallways and put in a full
day at school. She missed her senior prom and any social activities that a
normal senior in high school participates in. Her horse coulcl not be exercised
or jumped by her for a very long period of time. We have taken -to
many specialists in the New York area. They have no explanations for this
sudden dramatic change in her health except the probability that she had a
reaction to Lymerix which somehow caused an autoimmune reaction (because
of the bodies exposure to OspA). I am not as knowledgeable as this
distinguished panel of experts that I speak-to today, but I krnow one thing
with all of my being. It was Lymerix which somehow had this devastating
affect on my 17 year-old child. I think you have all considered that possibility
before today. Maybe after today you will think it is more than just a
possibility, you will see this drug can have some longlasting,dangerous side
effects. Just remember, I have been told this by many a doctor in the last
year and a half, they can treat and cure Lyme Disease but they cannot cure
an autoimmune arthritis. This is an 18year old who will never again be able to
run to catch a bus, or jump her horse with abandon. Her life will be forever
changed by Lymerix. Please consider this very carefully when making your
decisions about giving this to children.
3.) CASE No 3
To Whom It May Concern,
January 23,200l
In 1999 I was a very healthy 40 year old. Very active with my 10 year
old son, skating, bowling and biking. My only health complaint was
migraines and daily headaches. On May 21 ,I 999 I received the Lymetix
vaccine. With 24 hours I had flu like symptoms, body aches and low
grade fever. I did not think much of it being a nurse and knowing that this
is a common reaction to vaccines. Two weeks after the shot I woke up
and my right elbow was hurting and with a few days the body aches
returned. By the time I went for my second injection I had complained to
my doctor that I was hurting from head to toe and the fatigue was

He did not think it was related to the vaccine, because he had
heard nothing about any adverse reactions. I had the second injection
that day and my life has been a living hell since. Within 48 hours I was in
severe joint and body pain, that has not stopped. I tried seeing doctors
and no one knew anything about this vaccine and the realctions it was
causing. I was diagnosed with CFS, fibromalagia, and was even told it
could be stress from my job. I am a Hospice nurse and love what I do.
For months I went through this pain without any help from1 the medical
field. I wake up in the mornings and my husband has to help me out of
bed because the pain is so severe.

Four times I have been paralyzed,three from my wrist down and once from
my neck down for up to 20 minutes. I am scared that I my wake up
one day and not be able to move ever again.

I have since seen a doctor that told me I have an auto-immune reaction to
the vaccine that is untreatable and incurable. I am presently under the
care of a pain management doctor. If it was not for the medicine I
would not be able to get through my day. I still wake in the mornings with
severe, debilitating pain. I have to keep the pain medicine by my bed to
get up.

I have had very odd occurrences of unexplained symptoms. I have small
areas on my body that become red and feel as if they are burning, like fire,
from the inside. The fatigue is unbearable at times, especially with having a
10 year old. I am unable to enjoy being active with him like before.

I have been in contact with nearly 75 people that have been harmed by
this vaccine. It is destroying peoples life’s. It is hurting our most healthy
population. The population that goes out doors for different activities, they
are now bedridden or in such severe pain they are unable to move about
with daily activities without difficulty.

This reaction is not just hurting a certain age group. I have been contacted
by people from the age of 17 and up. I ask the committee to recommend
that this vaccine be taken off the market before more people are hurt.

As of May 8, 2000 there were 467 adverse reactions reported to VAERS,
and of them 144 had complained of some sort of joint pain. Please do not
let this vaccine hurt anymore people. I know SmithKline is trying to get it
approved for children, PLEASE DO NOT LET THEM HURT ANYMORE
Thank you,
4.) CASE No 4
Su bj:
Lymerix Vaccine
Wednesday, October 11, 2000 9:s 1:04 AM

I know that I am having a reaction to the lymerix vaccine. My nightmare
started with the second shot which I received sometime in 8/99. I had flu
like systems which turned into joint pain which has lasted around a year. I
reiceived the last shot in 7/00 and have been sick ever since. I have such
joint pain that it is hard to even get out of bed some days. I have had every
kind of blood work done that you can imagine. 1 am being treated by a

I have been on prednisone for the last six weeks. In four
weeks he will be starting me on Methotrexate. I was only 36 yrs old when
this whole thing started I just recently turned 37 yrs old and feel like I am
80. I have to young children we live in a high tic area I will never allow them
to have this vaccine. The FDA and my MD should have gave some sort of
warning that is could happen. Also,the adverse reaction form that you have
to fill out is almost impossible to get the information for that. I thought I
was protecting myself from getting

sick I didn’t realize that I was allowing the government and my doctor to
make me sick. 1 just hope some day 1 will feel better. Thank you
5.) CASE No 5
My name is
. and I am HLA-DM positive.
Eighteen months ago I ran five miles a week and worked
out at least an hour a day. I was very healthy and had no
health problems at all.

Within six months of getting the lymerix vaccine, I
couldn’t get out of bed by myself and was in constant
excruciating joint and muscle pain. My joints have started
making snapping sounds. I now get muscle aches in my
legs and I have a hard time walking. My feet feel like they
are on fire and get swollen. There are days when I all I can
do is stay in bed and cry because I am in so much pain.
Every week my body goes thru some other type of pain. It
moves from elbows to the knees to the hips to the leg
muscles. I also get cold spots that move around on my

I have been tested for Lupus, Crohns Disease and MS
and they are negative. Smithkline should not be able to
destroy peoples lives as they have destroyed mine. The
FDA let them put this on the market without fully testing
it. The longer that this is left on the market, the more
people are going to get hurt. Please stop this madness and
take it offthe market.
Thank You,
6.) CASE No 6
January 9, 2001
To whom it may concern,
My name is :-
-My phone number is –

I was diagnosed with Lyme disease on October, 1991 by Doctor –
and was treated with oral antibiotics. In July of 1998, I was reinfected and
was treated by Doctor –
with oral antibiotics. At his suggestion, I had the
LymeRex vaccine on April 23, 1999 (LY 10482 exp. 1 O/21 /99) and the booster on May
24, 1999 (LY 123A9 exp. 2/l 7/00).
After several months, I was experiencing hand pains and a decrease in function. X-rays
of my hands were ordered plus a blood test for HLA-DR4. I tested positive for the auto
immune factor and my Doctor told me not to have the additional booster shot.
I feel that the pains in my hands, wrists, shoulders, knees, ankles and neck are directly
caused by reaction to the LymeRex vaccine. My hands are affected the most, I can
hardly turn faucets, jar covers, door handles, etc. Since I am a realtor, the pains in my
hands and feet are interfering with my job performance.

My Doctor was never notified by Smith Kline to test for the auto Immune blood factor.
He also was unaware that the vaccine should not be administered to people who were
already infected. Why weren’t the Doctors informed by Smith Kline of these limitations?
I would not be experiencing the pain and diminished use of my hands if I had been told
not to take the vaccine.
Sincerely yours,
7.) CASE No 7
January 1,200l
To Whom It May Concern:

I am a positive, determined 40-year old woman who has recently had an extreme medical
setback. I have run three (3) marathons since 1995 and have been in excellent condition ah
of my life. I have played sports in high school, in college, and have continued
to run and bike tremendous distances up until the Fall of 1999.

Please be advised that after receiving my initial Lymerix vaccination in April of 1999 and
my second Lymerix vaccination in May of 1999, I developed the following adverse
In October of 1999 while training for my fourth marathon, I suddeuly became extremely
fatigue and sluggish. I could no longer physically run, as if my legs ‘were knocked out from
under me. I then developed severe joint and muscle pain throughout my entire body in
January of 2000.
My autoimmune system was also greatly affected. I developed full-blown Raynaud’s
Disease in my hands in March of 2000. There has been a total lack of circulation in my
hands and severe cracking in my finger tips. I can no longer tolerabe temperatures below
50 degrees.

I then received my third Lymerix vaccination in May of 2000. I have never felt so
discouraged and depressed over no longer being able to physically exercise! There has been
no improvement with the fatigue and achy joints even though I have been on anti-
inflammatories since May of 2000 and antibiotics since October of 2000.

This has been extremely difficult for me both physically and emotionally. I have always
been healthy and active, and now I can no loner live my live with xest and the way I know
how!. It is totally devastating!
8.) CASE No 8
January 4,2001

In April of 2000, after seeing LymeRix ads on television and a poster in
my doctor’s office, I decided to have the vaccine. Since my husband and I
love many outdoor activities including travelling, gardening, canoeing and
walking in woods with our dogs, I thought the vaccine would protect him as
well. We both had LymeRix in April and May.

In July, he began to have neurological symptoms and weakness, which
were diagnosed in August as Guillain-Barre Syndrome. He was hospitalized
following an electromyography, nerve conduction studies and a spinal tap.
Released to outpatient physical therapy 5 days later, he continued to grow
weaker. In September, he was rediagnosed with Chronic Inflammatory
Demyelinating Polyneuropathy and hospitalized again for 9 days. Despite
continuing medical care and bi-weekly rounds of plasmapheresis treatments,
his condition has continued to deteriorate. A recent repeat of the
electromyography and nerve conduction studies-showed “severe sensory,
motor, axonal and demyelinating neuropathy . . ..In comparison with the
August 2000 study, the neuropathy has increased substantially”.

The .neurologist has reported the disease to VAEXS as a vackine atdverse event.
My husband was director of the training program at the -_.-.For 33 years, he has
earned his living by walking 10 or more miles a day in the performance of his
job responsibilities. His retirement was planned for 2001, so he could have
more time to enjoy his family and hobbies, but he is so profoundly disabled
that he is unable to walk independently, get into bed or the s:hower. Personal
care is accomplished only through great effort. Our plans now revolve solely
around medical appointments and physical therapy.

No one else should ever suffer such profound life changes through the
administration of a “safe” vaccine. He would have been far better off to get
Lyme Disease than to be incapacitated by something we counted on to protect
his health!
9.) CASE No 9
MY name is *
dndIlive~inNorfh f2entdbdima. I am 55
years old and for the last 27 years I have beenan

1 was always pretty healthy and very active with interests and
hobbies that included hunting, fishing, and golf mainly. I am 6 foot 1 and
weighed 210 Ibs. 1 stayed in reasonably good shape Erom activities and
In the spring of 1999 our Department decided to give us LYMErix vaccine
and told us it was safe and ef%ective. After my second shot in August of
1999 I experienced extreme rib soreness and went ‘for a chest X ray, then
developed tennis .elbow, a stiff knee, and sharp pain in my left hip, along
with increasing~weakness in my legs.

By December my legs ached and Ifelt flu like sometimes and had
to rest more than usual. On Jarmary 30,2000 fny health nose-dived to
where I could not function at all. ‘I did-not know what was wrong
with me, but did not consider lyme disease, since we were told
you could .not get lyme disease from the vaccine. My life
fell into a black hole. 1 became super sensitive to light and sound and was
living in a darkened bedroom with earplugs, with occasional blind folded
trips to various doctors to try and get a diagnoses. I thought that I would
die and many times wished that I would because I felt so bad. Finally in
March the Doctors started looking at Lyme disease and I tested positive.

My current health is better Corn the neurological problems. I am still
unable to work, as I have no strength, especially in my legs. Sometimes
my knees hurt and burn like there is liquid fire in them My hips and
shoulders hurt and ache every day. My right index finger is too stiff to
bend and my left thumb hurts. It is obvious that I will suffer for a long
time because I let them inject a foreign substance called LYMErix into my
body If I had know about the HLA-DR4 theory of arthritis or that booster
shots would be needed, you would not be reading this, because I would
not have consented to the vaccine!! Even though my occupations is high
risk, my work area is low risk and not endemic.

Please stop this vaccine from wrecking more lives! !
Respectfully submitted
10.) CASE No 10
January 12,200l

To Whom It May Concern,

This letter is to inform you of my symptoms, tests and treatments since receiving the
Lymerix vaccine in 1999.

I was diagnosed with Lyme disease in October, 1998, after noticing a large red rash on
my right hip in July, 1998. The rash eventually disappeared, but my hip became very
sore and I developed a limp. Hip pain and fatigue were my only symptoms. A western
blot in October, 1998, confirmed Lyme disease. I began taking oral C’efuroxime –
500mg/twice a day for three weeks. At the end of this period, I still had some hip pain so

I was placed on IV Rocephin – 2 grams/day for four weeks. At the end of this time I was
almost pain-free and after several weeks of physical therapy had no pain whatsoever. I
continued symptom free until May, 1999, after the second Lymerix vaccine. The vaccine
was strongly recommended by the infectious disease physician who had treated me for
lyme disease and felt I would be an excellent candidate for the vaccine.

I received the first vaccine on April 12, 1999, and the second on May ‘7, 1999. Due to the
onset of symptoms, I did not receive the third dose. Below are the symptoms I have
experienced since the second vaccine. These symptoms began within :2 weeks of the
second dose.
-Sinus headache and pressure.
-Tingling in my hands, arms, legs and feet. It is worse when I am lying down and can be
so severe in my arms and hands that it wakes me up. It also occurs while showerin&
sneezing yawning or coughing.
-Burning in my knees, legs, feet and arms.
-Pain in my knees and hips
-Stiffness, weakness and trembling in my right hands and arms. Pain in my right wrist.

This is currently my worst symptom. I find activities such as reading, writing, etc., can
cause soreness and burning to develop in my arm and wrist, and tremor as well.
-Pain in the knuckles of my hands.

-A pulsating feeling in my head and arms. A feeling similar to a tremor, but there is no
visible signs of a tremor.-Small exploding burst of pain/heat all over my body. I know
this sounds odd, but it feels somewhat like a bee sting f?om the inside and is very short-
lived. I have experienced this sensation in many areas of my body.

-Lightheadedness, and an inability to focus/concentrate. It almost feels like my
equilibrium is off, however I do not feel dizzy, more like I’m in a fog.
-A slight jerking movement of my body or a part of my limbs as I lay down and rest.
-Monthly menstrual migraines that began immediately after the vaccine and continued for
10 months.
-The sensation of my stomach turning over, however, it is in my head. I know this
sounds unusual, but someone described it that way and it seemed perfect! This feeling
happens when I am lying down and can occur several times. It seems to occur over
several days and then will subside for a few weeks.

I do not experience all of these symptoms simultaneously, they seem to come and go
without any pattern or predictability. They all began after the second dose of the vaccine.
Listed below are the antibiotics I have taken since receiving the second vaccine.
1 l/22/99 – 0 l/28/00 Doxycycline 200mg/day
01/28/00 – 02/10/00 Doxycycline 3OOmg/day – Discontinued due to GI intolerance
02/13/00 – 03/23/00 Keflex
1500 mg/day – Discontinued due: to yeast infections
03/23/00 – 04/12/00 Zithromax
250 mglday
04/12/00 – 04/23/00 Zithromax
500 mg – Twice a week
05/19/00 – 06/29/00 IV Rocephin 6 week IV therapy
At the end of the IV treatment, I still had no improvement. In September, 2000, I saw Dr.
+ I. He is a physician who is treating chronic lyme
disease as a neurotoxin. I completed the treatment below, with’still no improvement.
09/24/00 – 1 O/l 6/00 Cholestyramine
4 grams per scoop/4 times per day
1 O/l 7/00 – 1 O/30/00 Cholestyramine
4 grams per scoop/4 times per day
750 mg/3 times per day
The following tests have been performed:
06/29/99 – MRI of the brain without/with contrast – result: normal
0710 l/99 – Lyme, Western blot. Positive.
07/28/99 – MRI of the brain with attention to the pituitary – result: 2mm microademoma
in the right side of the pituitary gland. This is something I have been a.ware of for 10
years and has been followed on a regular basis by my endocronologist. This finding does
not reveal any significant change in the microadenoma since my last MRI.
08199 – EKG – result:normal
09/20/99 – Median Nerve Evoked Potential – result: normal
09/20/99 – Posterior Tibial Evoked Response – result: normal
09/23/99 – MRI, cervical without contrast – result: normal
01/13/00 – Lumbar Puncture – result: borderline lyme serology. I t has been brought to
my attention that since a serum sample was not taken at the same time, this result is
irrelevant. I do not know why a serum sample was not ordered.

Thank you for your attention to this matter.
11.) CASE No. 11


I am a fifty-one year old woman who has survived Rheumatic Fever, Child birth
complications, a hysterectomy at the age of 27, and a three year bout with Lyme Disease
from 1987 to 1990. I have always been a fighter, and after each setback., I battled

my way back to a useful life.
This time is different. At the prompting of my insurance company and my
doctor, I received my first Lyme Vaccine shot on 5/4/99 and the second on
6/4/99. No one even thought to test me for a gene that would say I was
allergic to the shots. Suffering additional and increased health problems after the first two
shots, which included neuropathic pain in my legs and feet, migraines and other
headaches, severe sinus problems, chronic fatigue syndrome, depression, having to
double my medication (a Parkinsons drug called Mirapex) which was prescribed to me
for Restless :Leg Syndrome which began during my first bout with Lymes, I again took
the advice of my physician and got the third Lyme Vaccine shot in June of 2000.

From this point things went very wrong extremely fast, and I was able to
put it all together, placing the blame where it belonged, on the vaccine
shots for Lyme disease. My emotions went crazy, causing uncontrolled crying
spells while I was in school where I am learning computers. I became
extremely co&.sed (Lyme victims call it brain fog) and had to drop two of
my classes..My Restless Leg Syndrome, mostly, up to this point, medication controlled
jerking of the legs when I relaxed, suddenly began causing severe insomnia, jerking
of my head and left hand, and muscle spasms in my legs that my medication
would not stop. Fearing Parkinson’s, I was evaluated by two therapists who
were concerned because of a noticeable facial tic as well as a neck jerking.

My doctor suspected a late sequela of late treated Lyme’s disease and put me
on Lorazepam to calm my nerves, which did help my nerves, but nothing else.
Althougtl de&ed the possibility that the vaccine shots could have caused
my problems, she did agree to give me 28 days of doxicycline on the chance that

it might stop the irreversible neurological damage I was suffering. I began
to feel much better, and have done quite well until the past month when. my
left knee, my lower back, hips and neck have once again begun causing me
pain. (I had been pain free for at least two years before I got these shots) Although I was
never able to recall many things from my first bout with Lymes, I have been perfectly
able to relearn, as my two Scholarships and 3.868 Grade Point Average prove, but now

my memory is beginning to fail me again. I am signed up for three classes this neti
semester, and am so af?aid that I won’t be able to complete them. I want so badly to be
independent, to get a job that I can do over the intemet where I could w,ork around the
physical limitations I already had from Lyme Disease, but the additional fatigue, physical
and mental limitations inflicted upon me from these Lyme vaccination shots are &e last
straw. Unless I can receive some serious and immediate help, I fear I may soon be of no
use to anyone. I beg you to stop these vaccines now! Don’t let anyone, especially
children, suffer from them ever again.
12.) CASE No 12
fri 19 jan 2001
to whom it may concen
my name is
had the 3 shot series of the lyme
vaccine. june 13 th, 2000 was shot 3 of 3. six days later on 19 june
2000 i woke up with swollen , tender, and painfull knees and both
quadracept leg muscles hurt. the night before i had no prolblem at all.

it just came from nowhere without any warning symptoms.
during the following month my legs became weak and i noticed my leg
muscles getting smaller.after a quadracept biopsy and leg nerve
conduction tests i was diagnosed with muscle atophy and demyelination of
the nerves.

Approximately 1 aug 2000 i woke up with excruiating pain in my left hip.
i was first diagnosed with hip tendonitis then avascular necrosis and
then with an arthritic hip. this was all done with x-rays and mri”s.
in Sept. 2000 my left knee became so painfull i was told to use a cane,
which is the only way i can move now.

i was using oxyconyin 20 mg twice a day with no affect on the pain. i am
now on percocet S/325 about 5 times a day, just to take the extreme pain
away from my body, but it has no affect on my hip and knee pain.
my history is that in 1991 i had arthritis, scoliosis, hemochromatosis.
degenerative spine ,and degenerative lumbar area with stenosis of L3/L4
vertebrea causing sciatica. all the conditions starting with 199 1 have
been under control and stabilized with nsaids(feldene) for arthritis,theraputic
phlebotomys for hemochromatosis, and gravity lumbar
traction for the sciatica. i have been on social security disability

since 1995. i am currently 62 years old.
when on S.S. disability i could not work ( i was an electronics teacher
for 30 years ),because of low back pain , sciatica, and constant
gravity lumbar traction. now , i have no quality of life. i get around
on the cane and my right leg with great pain. i am very depressed and
fear-full of what migth happen next to my body as i live alone. if my
right leg goes, im dead in the water.

thanks .-
MON 14:29 c
i__ b_.-A
. . .

Good afternoon, my’ name is
I am from Wenham Massachusetts, one of the most Lyme-endemic areas in the US. I am a
member of ActionLyme, advocating for Lyme patient rights and the

Lyme information
and support group in my community.
I work locally with schools, parents and Lyme patients to raise awareness
of Lyme disease in our area, and I have read through much of what has
been written on Lymerix, especially the material provided by the CDC and

I come before you today as a mother of two, a consumer, and a patient
advocate, with issues that have occurred to others and me as we carefully
review the material on this vaccine.

1 pose these issues in the form of questions and hope this committee
sees fit to pursue answers to these important questions and concerns
before more aggressive marketing of the vaccine is allowed, especially to
our children.

I am a layperson –not a scientist. However others and myself have read
material published by the government and SmithKline Beecham and we
recognize the disparity between real- world experience and the reality of
the trials used to study the safety of‘Lymerix vaccine. I am sure my
questions are those that might be asked by any mother living in a Lyme-
endemic area, I pose them to you here, today with hope you will consider
the answers to these troubling questions before Lymerix is marketed to
our children.

I. The case definition of Lyme disease used for the vaccine is different
than the definition the CDC instructs our physicians to use when
diagnosing and treating Lyme. Given this disparity, how can we have
confidence that the vaccine trials reflect true patient situations?

2. Many individuals I know have claimed adverse events after receiving
the Lymerix vaccine, yet have been told their reports are ulnconnected to
the vaccine. How can so many people have the same type of reaction
directly after being vaccinated with Lymerix without it being vaccine

3. My children and I have had Lyme disease. I have read literature stating
the Lyme infection may persist, possibly hidden, in human cells after a
patient has been treated. What attentions have the Lymerix vaccine
makers taken to assure previously infected patients will not be harmed by
their vaccine?

4. The children playing in the forests and along the beaches of our
Massachusettstowns have been exposed to Lyme disease since they
could crawl. What of the children who have not been diagnosed with

nJ ,‘zz/ol
YON 14: 30
Lyme but do indeed’harbor the infection? What effect would Lymerix
vaccination produce in these innocents?
With new reports of asymptomatic

Lyme disease now abounding, 1 would
like to ask SmithKline Beecham how this possibility has been accounted
for in the study of safety of Lymerix for pediatric use.

I urge the committee to be prudent while reviewing the safety of thisvaccine.
Thank you for allowing me this opportunity.
Page 20
From –
o. Nancy Cherry
Date: l/21/01
Time: 1:45:48 PM

January 2 1, 200 1
Dear, Nancy Cherry
I’m writing this in reply to my concerns about Lymerix.
1. Doctors don’t know how to handle the rash of side effects.
2. Doctors don’t want to feel their at fault for the vaccine causing effects.
3. Patients are suffering because doctors don’t want to deal with Lyme let alone the vaccine
14.) Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes
that elicits bactericidal antibody responses: Implications for vaccine development.
Vaccine. 2017 May 31;35(24):3178-3185. doi: 10.1016/j.vaccine.2017.04.079. Epub 2017 May 4.

Izac JR1, Oliver LD Jr1, Earnhart CG1, Marconi RT2.
Author information
Dept. Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, VA, United States.
Dept. Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, VA, United States. Electronic address:
The lipoprotein OspA is produced by the Lyme disease spirochetes primarily in unfed ticks. OspA production is down-regulated by the blood meal and it is not produced in mammals except for possible transient production during late stage infection in patients with Lyme arthritis. Vaccination with OspA elicits antibody (Ab) that can target spirochetes in the tick midgut during feeding and inhibit transmission to mammals. OspA was the primary component of the human LYMErix™ vaccine. LYMErix™ was available from 1998 to 2002 but then pulled from the market due to declining sales as a result of unsubstantiated concerns about vaccination induced adverse events and poor efficacy. It was postulated that a segment of OspA that shares sequence similarity with a region in human LFA-1 and may trigger putative autoimmune events. While evidence supporting such a link has not been demonstrated, most efforts to move forward with OspA as a vaccine component have sought to eliminate this region of concern. Here we identify an OspA linear epitope localized within OspA amino acid residues 221-240 (OspA221-240) that lacks the OspA region suggested to elicit autoimmunity. A peptide consisting of residues 221-240 was immunogenic in mice. Ab raised against OspA221-240 peptide surface labeled B. burgdorferi in IFAs and displayed potent Ab mediated-complement dependent bactericidal activity. BLAST analyses identified several variants of OspA221-240 and a closely related sequence in OspB. It is our hypothesis that integration of the OspA221-240 epitope into a multivalent-OspC based chimeric epitope based vaccine antigen (chimeritope) could result in a subunit vaccine that protects against Lyme disease through synergistic mechanisms.
15.) Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
J Exp Med. 1996 Jan 1;183(1):271-5.

de Silva AM1, Telford SR 3rd, Brunet LR, Barthold SW, Fikrig E.
Author information
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8031, USA.
Borrelia burgdorferi, the spirochetal agent of Lyme disease, is transmitted by Ixodes ticks. A vaccine based on B. burgdorferi outer surface protein (Osp) A protects mice from spirochete infection. Here we report on the expression of OspA on spirochetes inside engorging ticks and relate OspA expression to antispirochetal immunity. Spirochetes in the gut of unfed nymphal ticks were stained by an OspA antibody, whereas in feeding ticks, the majority of spirochetes in the gut and salivary glands did not stain with the antibody. Thus, OspA was not expressed on most spirochetes during transmission from the vector to the vertebrate host. To examine the mechanism of protection afforded by OspA antibody, mice were passively immunized with OspA antibody at different times relative to tick attachment. When OspA antibody was administered to mice before or at the time of tick attachment, spirochetal development events in the vector, such as growth and salivary gland invasion, were blocked and the mice were protected from B. burgdorferi infection. When OspA antibody was administered to mice 48 h after tick attachment, spirochetes persisted in the nymphs and the mice were not protected despite the presence of circulating antibodies in the host as well as in the tick blood meal. Thus, OspA immunity appears to be effective only during a narrow window time at the beginning of the blood meal when antibodies bind to OspA-expressing spirochetes in the tick gut and block transmission from the vector to the host.
16.) An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope.
Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1303-8. Epub 2004 Jan 23.

Willett TA1, Meyer AL, Brown EL, Huber BT.
Author information
Department of Pathology, Tufts University School of Medicine, 150 Harrison Avenue, Boston, MA 02111, USA.
The antigenic component of a common Lyme disease vaccine is recombinant outer surface protein A (rOspA) of Borrelia burgdorferi (Bb), the causative agent of Lyme disease. Coincidentally, patients with chronic, treatment-resistant Lyme arthritis develop an immune response against OspA, whereas those with acute Lyme disease usually do not. Treatment-resistant Lyme arthritis occurs in a subset of Lyme arthritis patients and is linked to HLA.DRB1*0401 (DR4) and related alleles. Recent work from our laboratory identified T cell crossreactivity between epitopes of OspA and lymphocyte function-associated antigen 1alpha(L) chain (LFA-1alpha(L)) in these patients. We generated a form of rOspA, FTK-OspA, in which the LFA-1alpha(L)/rOspA crossreactive T cell epitope was mutated to reduce the possible risk of autoimmunity in genetically susceptible individuals. FTK-OspA did not stimulate human or mouse DR4-restricted, WT-OspA-specific T cells, whereas it did stimulate antibody responses specific for WT-OspA that were similar to mice vaccinated WT-OspA. We show here that the protective efficacy of FTK-OspA is indistinguishable from that of WT-OspA in vaccination trials, as both C3H/HeJ and BALB/c FTK-OspA-vaccinated mice were protected from Bb infection. These data demonstrate that this rOspA-derived vaccine lacking the predicted cross-reactive T cell epitope, but retaining the capacity to elicit antibodies against infection, is effective in generating protective immunity.
17.) Safety, immunogenicity, and efficacy of Borrelia burgdorferi outer surface protein A (OspA) vaccine: A meta-analysis.
J Infect Dev Ctries. 2017 Jan 30;11(1):1-9. doi: 10.3855/jidc.7999.

Zhao H1, Bao FF, Liu A.
Author information
Kunming Medical University, Kunming, China.
Lyme borreliosis, caused by Borrelia burgdorferi sensu stricto in the United States and by several Borrelia species in Europe and Asia, has a great impact on the health of the global population. There are human vaccines available, such as the outer surface protein A (OspA) vaccine, but still more evidence is needed to verify its function. We investigated the safety, immunogenicity, and efficacy of adjuvanted or non-adjuvanted vaccines containing protective epitopes from Borrelia species OspA serotypes in healthy adults.
Seven electronic databases were searched for clinical trials involving vaccine of OspA, with outcome data on safety, immunogenicity, and efficacy. The meta-analysis method was used to compare all vaccination strategies at the same time.
Three relevant studies were identified. All were randomized controlled trials (RCTs) or quasi-RCTs. Meta-analysis shows that, compared with low dose, high dose comes with a higher IgG titer with overall effect size of 6.39. For the 30 µg dose, the geometric mean titer was 6918.31, which is statistically significant when compared with 0. With respect to safety, only soreness showed a relatively high incidence of 40% (p < 0.05 when compared with 0, while the other side effects were no difference compared with 0).
The OspA vaccine against Lyme disease is safe and its immunogenicity and efficacy have been verified. Instead of stagnating or giving up, further research on improving the vaccine is needed. On the foundation of preliminary studies, we can attempt to develop new vaccines for human use.
18.) Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.
Vet J. 2016 Dec;218:27-33. doi: 10.1016/j.tvjl.2016.11.001. Epub 2016 Nov 9.

Oliver LD Jr1, Earnhart CG1, Virginia-Rhodes D1, Theisen M2, Marconi RT3.
Author information
Department of Microbiology and Immunology, Virginia Commonwealth University Medical Center, 1112 East Clay Street, McGuire Hall Room 101, Richmond, VA 23298-0678, USA.
Department of Congenital Disorders, Statens Serum Institute, Copenhagen, Denmark.
Department of Microbiology and Immunology, Virginia Commonwealth University Medical Center, 1112 East Clay Street, McGuire Hall Room 101, Richmond, VA 23298-0678, USA. Electronic address:
OspC performs essential functions during the enzootic cycle of the Lyme disease (LD) spirochetes. In this study, the specificity of antibody (Ab) responses to OspC was profiled to define the antigenic determinants during infection and after vaccination. Several OspC variants or ‘types’ were screened with serum from SNAP4Dx C6 positive dogs and with serum from rabbits hyperimmunized with OspC proteins. The OspC type-specific nature of the Ab response revealed that variable domains of OspC are immunodominant during infection and upon vaccination. To assess the potential of OspC to elicit Ab in the context of a bacterin vaccine, OspC production in strains cultivated in vitro was assessed. Immunoblot and indirect immunofluorescent antibody analyses demonstrated that production is low and that only a subset of cells actively produces OspC in vitro, raising questions about the potential of bacterin vaccines to stimulate significant anti-OspC Ab responses. The specificity of the OspC Ab response in experimentally infected mice over time was assessed to determine if domains shielded in the OspC homodimer become accessible and stimulate Ab production as infection progresses. The results demonstrate that the OspC Ab response remains focused on surface exposed variable regions of the protein throughout infection. In contrast to some earlier studies, it is concluded that conserved domains of OspC, including the C7 or C10 domain, do not elicit significant Ab responses during infection or upon vaccination. Collectively, the results indicate that OspC diversity must be considered in vaccine design and in the interpretation of diagnostic assays that employ OspC as a diagnostic antigen.
19.) Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.
Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00306-16. doi: 10.1128/CVI.00306-16. Print 2017 Jan.

Edmondson DG1, Prabhakaran S1, Norris SJ1, Ullmann AJ2, Piesman J2, Dolan M2, Probst C3, Radzimski C3, Stöcker W3, Komorowski L4.
Author information
Department of Pathology & Laboratory Medicine, Medical School, University of Texas, Houston, Texas, USA.
Centers for Disease Control and Prevention, Division of Vector-Borne Disease, Fort Collins, Colorado, USA.
Institute of Experimental Immunology, Euroimmun AG, Lübeck, Germany.
Institute of Experimental Immunology, Euroimmun AG, Lübeck, Germany
Lyme borreliosis is caused by tick-transmitted spirochetes of the Borrelia burgdorferi sensu lato group and is the most common vector-borne disease in the United States and Europe. Outer surface protein C (OspC) is a 23-kDa outer surface lipoprotein expressed during spirochete transmission from the tick to the vertebrate host. In a previous study, we found that immunization with a recombinant disulfide-bridged dimeric form of OspC (D-OspC) stimulates increased antibody responses relative to immunization with commonly employed monomeric OspC. Here, we report that mice immunized with dimeric OspC proteins also exhibited enhanced protection against infection with the cognate B. burgdorferi strain. Mice were protected by four immunizations containing as little as 100 ng of dimeric OspC, suggesting that this form of the protein can induce protective immunity within a dose range reasonable for a human or veterinary vaccine. In contrast, monomeric OspC was only partially protective at much higher doses. IgG subclass analysis revealed that D-OspC-immunized animals mainly possessed anti-OspC-IgG1. In contrast, infected animals develop anti-OspC restricted to the IgG3 isotype. A subset of antibodies generated by dimeric OspC immunization did not recognize the monomeric variant, indicating that unique epitopes exist on the dimeric form. Moreover, monoclonal antibodies that recognized only dimeric OspC protected mice from B. burgdorferi challenge, whereas another monoclonal that recognized both immunogens was not protective. These studies suggest that this dimeric OspC presents distinctive epitopes that generate antibodies protective against B. burgdorferi infection and could be a useful vaccine component.
20.) Intentions to receive a potentially available Lyme disease vaccine in an urban sample.
Ther Adv Vaccines. 2016 Jan;4(1-2):3-14. doi: 10.1177/2051013616629881. Epub 2016 Jan 1.

Fogel J1, Kusz M2.
Author information
Department of Business Management, Brooklyn College of the City University of New York, 218A, 2900 Bedford Avenue, Brooklyn, NY 11210, USA.
Department of Biology, Brooklyn College, Brooklyn, NY, USA.
The only human Lyme disease vaccine of LYMErix was voluntarily removed from the market in the United States in 2002 for a number of reasons. A new human Lyme disease vaccine is currently being developed. We would like any future approved human Lyme disease vaccine to be of interest and marketable to consumers.
We surveyed 714 participants to determine variables associated with intentions to receive a Lyme disease vaccine. Predictor variables included demographics, protection motivational theory, Lyme disease knowledge, Lyme disease preventive behaviors, beliefs and perceived health.
We found in multivariate linear regression analyses that Asian/Asian American race/ethnicity (p < 0.001), South Asian race/ethnicity (p = 0.01) and coping appraisal variables of response efficacy (p < 0.001) and self-efficacy (p < 0.001) were each significantly associated with increased intentions. The belief that vaccines are typically not safe was significantly associated with decreased intentions (p = 0.03).
Asian/Asian American and South Asian race/ethnicities have a strong interest in receiving a Lyme disease vaccine. Although pharmaceutical companies may benefit by advertising a Lyme disease vaccine to Asian/Asian Americans and South Asians, marketers need to address and use approaches to interest those from other race/ethnicities. Also, marketers need to address the erroneous belief that vaccines are typically not safe in order to interest those with such beliefs to use a Lyme disease vaccine.


Produced by Dr. Jose Lapenta R. Dermatologist
Maracay Estado Aragua Venezuela 2.017
Telf: 02432327287-02432328571



Excellent article & resource by Dr. Lapenta.  For more on the Lyme Vaccine:   a number of young women who fell ill after their HPV vaccination, which seems to have stimulated a latent Lyme infection to reactivate.  Asymptomatic girls after receiving Gardasil activated dormant Bartonella which was confirmed by testing.